Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, & State Efforts
New Missouri Bill Opens Door for Psychedelics Therapy
RIVERFRONT TIMES
Elaine Brewer thought she was out of options. Therapy didn’t solve her constant anxiety and depression. Nor did five different antidepressant prescriptions. Her husband, Heath...
Elaine Brewer thought she was out of options. Therapy didn’t solve her constant anxiety and depression. Nor did five different antidepressant prescriptions. Her husband, Heath...
Psychedelics Movement Marches Forward in These Four US States
PSYCHEDELIC SPOTLIGHT
Another Michigan city decriminalizes plant and fungi psychedelics, while Maryland passes landmark psychedelic legislation for veterans.
Another Michigan city decriminalizes plant and fungi psychedelics, while Maryland passes landmark psychedelic legislation for veterans.
Oregon Psilocybin Services Act
Oregon’s psilocybin program stands on thousands of years of indigenous experience
OREGON CAPITAL CHRONICLE
Indigenous shamans and guides treated people with psilocybin for a host of ailments, from anxiety and rheumatism to stomach pain.
Indigenous shamans and guides treated people with psilocybin for a host of ailments, from anxiety and rheumatism to stomach pain.
Oregon Psilocybin Rules ‘May Have Negative Impact on Lower Income Individuals’
PSYCHEDELIC SPOTLIGHT
The Oregon Health Authority admits its framework for legal psilocybin services will incur costs that will be passed down to consumers.
The Oregon Health Authority admits its framework for legal psilocybin services will incur costs that will be passed down to consumers.
Right to Try
DEA Under Fire For Blocking Psilocybin As Treatment For Terminally Ill Cancer Patients - Benzinga
BENZINGA
The Drug Enforcement Administration (DEA) will face activists at its headquarters in Arlington, Virginia. Protestors are intending to block entrance to the building to call attention to the rights of terminally ill cancer patients to try psilocybin as a palliative.
The Drug Enforcement Administration (DEA) will face activists at its headquarters in Arlington, Virginia. Protestors are intending to block entrance to the building to call attention to the rights of terminally ill cancer patients to try psilocybin as a palliative.
Protestors Target the DEA in Support of Psilocybin for Terminally Ill Patients
LUCID
David Bronner is spearheading a sit-in at DEA headquarters next month to demand access to psilocybin for patients under the federal “Right to Try” law.
David Bronner is spearheading a sit-in at DEA headquarters next month to demand access to psilocybin for patients under the federal “Right to Try” law.
Research, Therapy, & Science
Do Psychedelics Need Psychiatrists?
NEO.LIFE
As psychedelic drugs are poised to join the mainstream, what is the role of the prescriber?
As psychedelic drugs are poised to join the mainstream, what is the role of the prescriber?
Psychedelic frees up depressed brain, study shows
BBC NEWS
The drug found in magic mushrooms could treat depression in a unique way, researchers say.
The drug found in magic mushrooms could treat depression in a unique way, researchers say.
Psychedelics Bump Up Against the Iffy World of Healthcare Insurance
GREEN MARKET REPORT
Insurance for psychedelics is being explored with more vigor today as patients realize the enormous costs involved in such therapy.
Insurance for psychedelics is being explored with more vigor today as patients realize the enormous costs involved in such therapy.
Business
Can the Clever Use of Old Legal Strategies Thwart Psychedelic Monopolies?
VICE
Corporations are going to use IP law to profit from psychedelics. But creative strategies from other industries could help people push back against exclusionary ownership and keep drugs accessible.
Corporations are going to use IP law to profit from psychedelics. But creative strategies from other industries could help people push back against exclusionary ownership and keep drugs accessible.
Why Investors Should Care About MindMed’s LSD Trial for Anxiety
PSYCHEDELIC SPOTLIGHT
Our resident Psychedelic Investor explains why results from MindMed’s LSD-assisted therapy trial for anxiety disorder may be an opportunity.
Our resident Psychedelic Investor explains why results from MindMed’s LSD-assisted therapy trial for anxiety disorder may be an opportunity.
Psychedelic Business Spotlight: First Major Industry Merger and More
PSYCHEDELIC SPOTLIGHT
This week in psychedelic business news: The industry’s first major merger; NeonMind launches clinics; and a portfolio of patents is acquired.
This week in psychedelic business news: The industry’s first major merger; NeonMind launches clinics; and a portfolio of patents is acquired.
Culture
Bicycle Day: Honoring The Onset Of The Psychedelic Revolution As It Zooms Across The Globe
FORBES
This unofficial holiday for psychonauts is an opportunity to reflect on the history of psychedelics and the state of them now.
This unofficial holiday for psychonauts is an opportunity to reflect on the history of psychedelics and the state of them now.
Upcoming Events
FREE Virtual Event Series - Deep Dive Into Oregon Psilocybin Services Act: Business Formation and IRC 280E (Session 4).
EMERGE LAW GROUP
Our fourth session of our Deep Dive series will focus on business formation, and unique issues that arise when operating in a legal grey area, including IRC 280E.
Our fourth session of our Deep Dive series will focus on business formation, and unique issues that arise when operating in a legal grey area, including IRC 280E.
Subscribe
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
